Beckman Coulter Diagnostics, a global leader in clinical diagnostics and a Danaher company, today announced it received CE ...
Automated quality control using rapid PCR assays is replacing 28-day culture tests, cutting biopharmaceutical lot release ...
Countable Labs, the developer of Countable PCR, a breakthrough single-molecule PCR technology redefining how science measures ...
According to MarketsandMarkets™, the Body Fluid Analysis Market is projected to grow from about USD 2.62 billion in 2026 to ...
It’s a bit like giving the soil a DNA test.” A new droplet digital PCR (ddPCR) method quantifies root DNA directly from soil ...
According to MarketsandMarkets, the Body Fluid Analysis Market is projected to grow from about USD 2.62 billion in 2026 to USD 3.65 billion ...
The ADAPT study validates plasma p-tau217 assays against CSF standards, outlining optimal dual cut-points for clinical ...
Diazyme Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Diazyme Lipoprotein(a) Molarity Assay. This clearance enables clinical ...
As drug developers pursue increasingly complex therapies, traditional bioanalytical approaches are being put to the test. How ...
In modern biopharmaceutical manufacturing, maintaining stringent quality control (QC) for parenteral drug products is essential to ensuring product safety and regulatory compliance. Parenteral ...
There’s still work to be done to determine whether North American Niobium and Critical Minerals Corp.’s (CSE: NIOB) (FSE: KS82.F) (OTCQB: NIOMF) (NIOB or the Company) Seigneurie system hosts rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results